Disclosed are methods for treating a cognitive or neurological diseases and disorders comprising the step of administering rapastinel or a pharmaceutically acceptable salt, ester or metabolite thereof to a patient in need thereof, wherein rapastinel is administered for an administration period of about one to about fourteen days followed by a holiday period of at least about one to sixteen weeks wherein rapastinel is not administered.
